Overview

A Clinical Trial of Two Periarticular Multimodal Drug Injections in Total Hip and Knee Arthroplasty

Status:
Completed
Trial end date:
2018-08-21
Target enrollment:
Participant gender:
Summary
This study evaluates two routinely used drug combinations for periarticular injection following total hip and knee arthroplasty for pain control. One group will receive liposomal bupivacaine, bupivacaine, clonidine, epinephrine and ketorolac. The other group will receive ropivacaine, clonidine, epinephrine and ketorolac.
Phase:
Phase 4
Details
Lead Sponsor:
Kootenai Health
Treatments:
Bupivacaine
Clonidine
Epinephrine
Epinephryl borate
Ketorolac
Ketorolac Tromethamine
Racepinephrine
Ropivacaine